StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO - Free Report) in a research note published on Monday. The firm issued a strong-buy rating on the medical research company's stock.
Global Cord Blood Trading Up 4.0 %
CO traded up $0.04 during trading on Monday, reaching $1.05. 26,317 shares of the company's stock were exchanged, compared to its average volume of 216,519. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The stock has a market capitalization of $127.63 million, a PE ratio of 1.64 and a beta of 0.16. The firm has a fifty day moving average price of $1.11 and a two-hundred day moving average price of $1.36.
Global Cord Blood Company Profile
(
Get Free Report)
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.
Read More
Before you consider Global Cord Blood, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.
While Global Cord Blood currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
